| Nov 19 |
Evotec plunges amid report it's against Halozyme Therapeutics takeover
|
| Nov 18 |
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
|
| Nov 17 |
Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
|
| Nov 16 |
Key deals this week: Exxon, Unilever, Cardinal Health, Charter Communications and more
|
| Nov 15 |
Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
|
| Nov 15 |
Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
|
| Nov 15 |
Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
|
| Nov 15 |
Halozyme bids for Evotec; BeiGene gets a new name
|
| Nov 14 |
Germany’s Evotec Gets Takeover Interest From Halozyme
|
| Nov 14 |
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
|
